Description

Merck & Co., Inc. operates as a leading global healthcare enterprise. Its operations are structured into two primary segments: Pharmaceutical and Animal Health. The Pharmaceutical division is dedicated to offering human health solutions, encompassing prescription medicines for critical therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular health, and diabetes. This segment also provides a suite of vaccine products designed for preventive use across pediatric, adolescent, and adult populations. Conversely, the Animal Health segment is committed to the discovery, development, production, and commercialization of veterinary pharmaceuticals, vaccines, and comprehensive health management solutions. This also extends to sophisticated digitally connected products for identification, traceability, and monitoring of animals. The company's extensive customer base includes drug wholesalers, retail pharmacies, hospitals, and various governmental agencies. It also caters to managed health care providers, such as health maintenance organizations and pharmacy benefit managers, as well as individual physicians, physician distributors, veterinarians, and animal producers. Furthermore, Merck & Co., Inc. actively collaborates with several industry partners, including AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc., to jointly advance and bring to market long-acting treatments for HIV. Established in 1891, the company maintains its corporate headquarters in Kenilworth, New Jersey.